Corporate Banner
Satellite Banner
Biologics & Bioprocessing
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Mettler-Toledo Introduces New Webinar

Published: Friday, October 26, 2012
Last Updated: Friday, October 26, 2012
Bookmark and Share
Webinar explains how pharma manufacturers can optimize fermentation process.

Mettler-Toledo Process Analytics has released a new webinar intended for pharmaceutical producers involved in biofermentation.

The webinar explains how optimal microorganism growth conditions and consequently higher process yield can be achieved through a program of dissolved carbon dioxide measurement and control.

In biopharmaceutical operations, it is important that process reliability is high at all times. Central to this aim is timely measurement of analytical parameters.

Well known key process parameters include pH, dissolved oxygen, and turbidity. Less recognized but of significant importance in fermentation reactors is carbon dioxide.

Dissolved carbon dioxide levels can be indicative of the quality of cellular metabolism.

High levels of CO2 generally equate to high cellular growth; however, if CO2 levels are excessive, they can reach a concentration that is toxic to the microorganisms.

Low CO2 levels lead to a slow growth rate and extended process duration. In-line CO2 measurement systems provide continuous, real-time data on CO2 concentration levels, allowing rapid corrective action when required.

Mettler-Toledo’s on-demand webinar illustrates how dissolved CO2 measurement and control can keep fermentation cultures in their optimal growth range.

This consequently increases process yield and efficiency of the fermentation process.

The webinar also introduces Mettler-Toledo's InPro 5000i dissolved CO2 sensor, which has been designed specifically for the requirements of the pharmaceutical industry. The webinar is available at www.mt.com.


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,900+ scientific posters on ePosters
  • More than 4,200+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.


Scientific News
Natural Protein Points to New Inflammation Treatment
Findings may offer insight to effective treatments for inflammatory diseases, such as rheumatoid arthritis, psoriasis, and multiple sclerosis.
Tricked-Out Immune Cells Could Attack Cancer
New cell-engineering technique may lead to precision immunotherapies.
Therapy Halts Progression of Lou Gehrig’s Disease
Researchers at Oregon State University announced today that they have essentially stopped the progression of amyotrophic lateral sclerosis (ALS), or Lou Gehrig’s disease, for nearly two years in one type of mouse model used to study the disease – allowing the mice to approach their normal lifespan.
Crouching Protein, Hidden Enzyme
A new study led by scientists at The Scripps Research Institute (TSRI) and the University of California (UC), Berkeley shows how a crucial molecular enzyme starts in a tucked-in somersault position and flips out when it encounters the right target.
Utilizing Antibodies from Ebola Survivors
A collaborative team from The University of Texas Medical Branch at Galveston, Vanderbilt University, The Scripps Research Institute and Integral Molecular Inc. have learned that antibodies in the blood of people who have survived a strain of the Ebola virus can kill various types of Ebola.
Engineering Foe into Friend
Bose Grant awardee Jacquin Niles aims to repurpose the malaria parasite for drug delivery.
Important Regulator of Immune System Decoded
Plasma cells play a key role in our immune system. Now scientists at the Research Institute of Molecular Pathology (IMP) in Vienna, Austria, and at the Walter and Eliza Hall Institute (WEHI) in Melbourne, Australia, succeeded in characterizing a central regulator of plasma cell function.
Bacterial Superglue for Faster Vaccine Development
An interdisciplinary team of Oxford University researchers has devised a new technique to speed up the development of novel vaccines.
Enumeral, MD Anderson Enter Into Collaboration
Strategic collaboration aims to discover and develop potentially novel antibodies against specified targets for immunotherapy.
Joint venture for GlycoMar Limited and MicroA AS
Scottish biotechnology company GlycoMar and Norwegian technology company MicroA are pleased to announce their joint venture business Prasinotech Ltd. The new company is registered in Scotland.
SELECTBIO

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,900+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,200+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!